Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

CXCL10 impairs beta cell function and viability in diabetes through TLR4 signaling.

Schulthess FT, Paroni F, Sauter NS, Shu L, Ribaux P, Haataja L, Strieter RM, Oberholzer J, King CC, Maedler K.

Cell Metab. 2009 Feb;9(2):125-39. doi: 10.1016/j.cmet.2009.01.003.

2.

CXCR3, CXCL10 and type 1 diabetes.

Antonelli A, Ferrari SM, Corrado A, Ferrannini E, Fallahi P.

Cytokine Growth Factor Rev. 2014 Feb;25(1):57-65. doi: 10.1016/j.cytogfr.2014.01.006. Epub 2014 Jan 28. Review.

PMID:
24529741
3.

CXCL10 activities, biological structure, and source along with its significant role played in pathophysiology of type I diabetes mellitus.

Ahmadi Z, Arababadi MK, Hassanshahi G.

Inflammation. 2013 Apr;36(2):364-71. doi: 10.1007/s10753-012-9555-1. Review.

PMID:
23065240
4.

Control of pancreatic beta-cell fate by insulin signaling: The sweet spot hypothesis.

Johnson JD, Alejandro EU.

Cell Cycle. 2008 May 15;7(10):1343-7. Epub 2008 Mar 3. Review.

PMID:
18418065
5.

The multifaceted functions of CXCL10 in cardiovascular disease.

van den Borne P, Quax PH, Hoefer IE, Pasterkamp G.

Biomed Res Int. 2014;2014:893106. doi: 10.1155/2014/893106. Epub 2014 Apr 23. Review.

Supplemental Content

Support Center